TrialBritish journal of cancer2017

Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer.

Tudor-Eliade Ciuleanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.